nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—blood plasma—abdominal aortic aneurysm	0.0814	0.281	CbGeAlD
Ingenol Mebutate—PRKCA—artery—abdominal aortic aneurysm	0.0598	0.207	CbGeAlD
Ingenol Mebutate—PRKCA—Regulation of Ras family activation—DAB2IP—abdominal aortic aneurysm	0.0527	0.0741	CbGpPWpGaD
Ingenol Mebutate—PRKCA—blood plasma—abdominal aortic aneurysm	0.0449	0.155	CbGeAlD
Ingenol Mebutate—PRKCD—connective tissue—abdominal aortic aneurysm	0.0433	0.15	CbGeAlD
Ingenol Mebutate—PRKCA—EGFR Transactivation by Gastrin—MMP3—abdominal aortic aneurysm	0.029	0.0407	CbGpPWpGaD
Ingenol Mebutate—PRKCA—connective tissue—abdominal aortic aneurysm	0.0239	0.0825	CbGeAlD
Ingenol Mebutate—PRKCA—kidney—abdominal aortic aneurysm	0.0203	0.0703	CbGeAlD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.0174	0.0245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—spinal cord—abdominal aortic aneurysm	0.0158	0.0547	CbGeAlD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.0155	0.0218	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway—LDLR—abdominal aortic aneurysm	0.0151	0.0213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.0143	0.0201	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Nuclear Envelope Breakdown—AAAS—abdominal aortic aneurysm	0.0126	0.0177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PDGFR-beta signaling pathway—LRP1—abdominal aortic aneurysm	0.0121	0.017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Type II interferon signaling (IFNG)—NOS2—abdominal aortic aneurysm	0.0117	0.0165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IL-6 signaling pathway—AGT—abdominal aortic aneurysm	0.0114	0.016	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—LDLR—abdominal aortic aneurysm	0.0108	0.0152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.0104	0.0146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Syndecan-2-mediated signaling events—MMP2—abdominal aortic aneurysm	0.0103	0.0145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.00998	0.014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—NCF1—abdominal aortic aneurysm	0.00972	0.0137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—NCF1—abdominal aortic aneurysm	0.00918	0.0129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00889	0.0125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00878	0.0124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00868	0.0122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—LRP1—abdominal aortic aneurysm	0.00866	0.0122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Syndecan-4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.0085	0.012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Interferon Signaling—AAAS—abdominal aortic aneurysm	0.00826	0.0116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.00822	0.0116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.00767	0.0108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.00738	0.0104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.00718	0.0101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—LRP1—abdominal aortic aneurysm	0.00696	0.00979	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Validated transcriptional targets of TAp63 isoforms—CDKN2A—abdominal aortic aneurysm	0.00682	0.00959	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00674	0.00949	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—LDLR—abdominal aortic aneurysm	0.00657	0.00924	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.00649	0.00914	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—CDKN2A—abdominal aortic aneurysm	0.00635	0.00894	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00634	0.00891	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00629	0.00885	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Canonical NF-kappaB pathway—NFKB1—abdominal aortic aneurysm	0.00629	0.00885	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—LDLR—abdominal aortic aneurysm	0.0062	0.00873	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Ceramide signaling pathway—NFKB1—abdominal aortic aneurysm	0.00608	0.00855	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.00595	0.00838	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AAAS—abdominal aortic aneurysm	0.00575	0.00808	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic Prophase—AAAS—abdominal aortic aneurysm	0.00564	0.00794	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—NCF1—abdominal aortic aneurysm	0.00558	0.00786	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.00551	0.00776	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00539	0.00758	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—NCF1—abdominal aortic aneurysm	0.00527	0.00742	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.00522	0.00735	CbGpPWpGaD
Ingenol Mebutate—PRKCA—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—abdominal aortic aneurysm	0.00522	0.00735	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.00499	0.00703	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—MMP9—abdominal aortic aneurysm	0.00488	0.00687	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Syndecan-4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00488	0.00687	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—CDKN2A—abdominal aortic aneurysm	0.00488	0.00687	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.00483	0.00679	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00477	0.00671	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.00476	0.0067	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.00471	0.00663	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—NOS2—abdominal aortic aneurysm	0.00464	0.00653	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.00447	0.00629	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.00424	0.00597	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.00412	0.0058	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SELL—abdominal aortic aneurysm	0.00411	0.00578	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00398	0.0056	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—MMP2—abdominal aortic aneurysm	0.00398	0.0056	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00387	0.00545	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00374	0.00526	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—P2RY12—abdominal aortic aneurysm	0.0037	0.00521	CbGpPWpGaD
Ingenol Mebutate—PRKCD—TCR Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00368	0.00517	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00364	0.00512	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00361	0.00509	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—NFKB1—abdominal aortic aneurysm	0.00361	0.00508	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00351	0.00495	CbGpPWpGaD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00346	0.00487	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—APOE—abdominal aortic aneurysm	0.0034	0.00478	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AAAS—abdominal aortic aneurysm	0.0033	0.00464	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00329	0.00463	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00314	0.00442	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.00313	0.00441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—AAAS—abdominal aortic aneurysm	0.00304	0.00427	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	0.00292	0.0041	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—CDKN2A—abdominal aortic aneurysm	0.0028	0.00394	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—AAAS—abdominal aortic aneurysm	0.00278	0.00392	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00274	0.00385	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.00273	0.00385	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.00271	0.00381	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00266	0.00375	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.00257	0.00361	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.00252	0.00355	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.0024	0.00338	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.00238	0.00335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00236	0.00333	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SELL—abdominal aortic aneurysm	0.00236	0.00332	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00234	0.00329	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00229	0.00322	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00223	0.00314	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SELL—abdominal aortic aneurysm	0.00216	0.00303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00213	0.00299	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00212	0.00299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—AAAS—abdominal aortic aneurysm	0.00208	0.00293	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—NFKB1—abdominal aortic aneurysm	0.00207	0.00292	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.00196	0.00276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00194	0.00273	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—LRP1—abdominal aortic aneurysm	0.00192	0.0027	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—AAAS—abdominal aortic aneurysm	0.00186	0.00262	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00181	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AAAS—abdominal aortic aneurysm	0.0018	0.00253	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AAAS—abdominal aortic aneurysm	0.00179	0.00252	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00172	0.00242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AAAS—abdominal aortic aneurysm	0.00166	0.00234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.00149	0.0021	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00148	0.00209	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NCF1—abdominal aortic aneurysm	0.00147	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.00146	0.00205	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—LDLR—abdominal aortic aneurysm	0.00145	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NOS2—abdominal aortic aneurysm	0.00145	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00142	0.002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.00137	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NCF1—abdominal aortic aneurysm	0.00136	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00136	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00134	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00134	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00133	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00129	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00125	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SELL—abdominal aortic aneurysm	0.00124	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00122	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00122	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.0012	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.00118	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00116	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00115	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LRP1—abdominal aortic aneurysm	0.0011	0.00155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AAAS—abdominal aortic aneurysm	0.00103	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AAAS—abdominal aortic aneurysm	0.00103	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00102	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.001	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AAAS—abdominal aortic aneurysm	0.000955	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000951	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00091	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000902	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NCF1—abdominal aortic aneurysm	0.000845	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000837	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LDLR—abdominal aortic aneurysm	0.000834	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000831	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS2—abdominal aortic aneurysm	0.000831	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000818	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AAAS—abdominal aortic aneurysm	0.0008	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NCF1—abdominal aortic aneurysm	0.00078	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00077	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000764	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APOE—abdominal aortic aneurysm	0.000752	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000749	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000742	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000721	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—abdominal aortic aneurysm	0.000701	0.000986	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.0007	0.000985	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LDLR—abdominal aortic aneurysm	0.000698	0.000983	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.00069	0.000971	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000681	0.000958	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000662	0.000931	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000635	0.000894	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000617	0.000868	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SERPINE1—abdominal aortic aneurysm	0.00059	0.00083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000584	0.000822	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000575	0.00081	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000546	0.000769	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000537	0.000756	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000526	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000522	0.000735	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—abdominal aortic aneurysm	0.000515	0.000725	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NFKB1—abdominal aortic aneurysm	0.000484	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000478	0.000672	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000443	0.000623	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000439	0.000617	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—abdominal aortic aneurysm	0.000432	0.000608	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00043	0.000605	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000413	0.000581	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—abdominal aortic aneurysm	0.000402	0.000566	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000391	0.00055	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AGT—abdominal aortic aneurysm	0.000369	0.000519	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000365	0.000514	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—abdominal aortic aneurysm	0.000362	0.000509	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—abdominal aortic aneurysm	0.000339	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000316	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000313	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000309	0.000434	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000302	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—abdominal aortic aneurysm	0.000296	0.000416	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKB1—abdominal aortic aneurysm	0.000278	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000254	0.000358	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—abdominal aortic aneurysm	0.000248	0.000349	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000237	0.000334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000182	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00018	0.000253	CbGpPWpGaD
